113 related articles for article (PubMed ID: 27823764)
1. CXCR6 promotes tumor cell proliferation and metastasis in osteosarcoma through the Akt pathway.
Ma Y; Xu X; Luo M
Cell Immunol; 2017 Jan; 311():80-85. PubMed ID: 27823764
[TBL] [Abstract][Full Text] [Related]
2. TRAF4 enhances osteosarcoma cell proliferation and invasion by Akt signaling pathway.
Yao W; Wang X; Cai Q; Gao S; Wang J; Zhang P
Oncol Res; 2014; 22(1):21-28. PubMed ID: 25700355
[TBL] [Abstract][Full Text] [Related]
3. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.
Xiao G; Wang X; Wang J; Zu L; Cheng G; Hao M; Sun X; Xue Y; Lu J; Wang J
Oncotarget; 2015 Jun; 6(16):14165-78. PubMed ID: 25909173
[TBL] [Abstract][Full Text] [Related]
4. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
[TBL] [Abstract][Full Text] [Related]
5. Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways.
Dong F; Liu T; Jin H; Wang W
Can J Physiol Pharmacol; 2018 Jan; 96(1):1-7. PubMed ID: 28177668
[TBL] [Abstract][Full Text] [Related]
6. TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.
Chen Y; Guo Y; Yang H; Shi G; Xu G; Shi J; Yin N; Chen D
Oncotarget; 2015 Sep; 6(27):23708-19. PubMed ID: 26247633
[TBL] [Abstract][Full Text] [Related]
7. Blockade of CXCR6 reduces invasive potential of gastric cancer cells through inhibition of AKT signaling.
Li Y; Fu LX; Zhu WL; Shi H; Chen LJ; Ye B
Int J Immunopathol Pharmacol; 2015 Jun; 28(2):194-200. PubMed ID: 25921630
[TBL] [Abstract][Full Text] [Related]
8. Nitidine chloride suppresses epithelial-to-mesenchymal transition in osteosarcoma cell migration and invasion through Akt/GSK-3β/Snail signaling pathway.
Cheng Z; Guo Y; Yang Y; Kan J; Dai S; Helian M; Li B; Xu J; Liu C
Oncol Rep; 2016 Aug; 36(2):1023-9. PubMed ID: 27279040
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
10. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering.
Singh R; Kapur N; Mir H; Singh N; Lillard JW; Singh S
Oncotarget; 2016 Feb; 7(6):7343-53. PubMed ID: 26799186
[TBL] [Abstract][Full Text] [Related]
11. Neuropilin and tolloid-like 2 regulates the progression of osteosarcoma.
Wang X; Bian Z; Hou C; Li M; Jiang W; Zhu L
Gene; 2021 Feb; 768():145292. PubMed ID: 33157203
[TBL] [Abstract][Full Text] [Related]
12. [Expression of Chemokine receptor CXCR6 and its significance in breast cancer cell lines].
Cheng H; Chen NY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):405-9. PubMed ID: 24941806
[TBL] [Abstract][Full Text] [Related]
13. The DRF motif of CXCR6 as chemokine receptor adaptation to adhesion.
Koenen A; Babendreyer A; Schumacher J; Pasqualon T; Schwarz N; Seifert A; Deupi X; Ludwig A; Dreymueller D
PLoS One; 2017; 12(3):e0173486. PubMed ID: 28267793
[TBL] [Abstract][Full Text] [Related]
14. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.
Meijer J; Ogink J; Kreike B; Nuyten D; de Visser KE; Roos E
Cancer Res; 2008 Jun; 68(12):4701-8. PubMed ID: 18559516
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer.
Ha HK; Lee W; Park HJ; Lee SD; Lee JZ; Chung MK
Mol Med Rep; 2011; 4(3):419-24. PubMed ID: 21468586
[TBL] [Abstract][Full Text] [Related]
16. EZH2 promotes the progression of osteosarcoma through the activation of the AKT/GSK3β pathway.
Wan D; Han X; Zhang C; Zhang Y; Ma Y; Wang G
Clin Exp Pharmacol Physiol; 2022 Nov; 49(11):1179-1186. PubMed ID: 35818168
[TBL] [Abstract][Full Text] [Related]
17. CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer.
Deng L; Chen N; Li Y; Zheng H; Lei Q
Biochim Biophys Acta; 2010 Aug; 1806(1):42-9. PubMed ID: 20122997
[TBL] [Abstract][Full Text] [Related]
18. Escin suppresses migration and invasion involving the alteration of CXCL16/CXCR6 axis in human gastric adenocarcinoma AGS cells.
Lee HS; Hong JE; Kim EJ; Kim SH
Nutr Cancer; 2014; 66(6):938-45. PubMed ID: 24911042
[TBL] [Abstract][Full Text] [Related]
19. UBE2L3 Promotes Oxidative Stress-regulated Necroptosis to Accelerate Osteosarcoma Progression.
Zhao X; Shan G; Xing D; Gao H; Xiong Z; Hui W; Gong M
Recent Pat Anticancer Drug Discov; 2024 Feb; ():. PubMed ID: 38385491
[TBL] [Abstract][Full Text] [Related]
20. Plant flavonoid taxifolin inhibits the growth, migration and invasion of human osteosarcoma cells.
Chen X; Gu N; Xue C; Li BR
Mol Med Rep; 2018 Feb; 17(2):3239-3245. PubMed ID: 29257319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
